Patrick Dolezal

Item: Patrick Dolezal
Rating: 2.57
Author: StockAnalysis.com

Stock Analyst at LifeSci Capital

(2.57)

# 2,156

Out of 5,147 analysts

Total ratings

100%

Success rate

30.37%

Average return

Main Sectors:

Top Industries:

Stocks Rated by Patrick Dolezal

	Stock	Action	Price Target	Current	Upside	Ratings	Updated
	NGNE Neurogene	Initiates: Outperform	$50	$23.49	+112.86%	1	Jan 26, 2026
	KOD Kodiak Sciences	Initiates: Outperform	$40	$26.80	+49.25%	1	Oct 23, 2025

Neurogene

Jan 26, 2026

Initiates: Outperform

Price Target: $50

Current: $23.49

Upside: +112.86%

Kodiak Sciences

Oct 23, 2025

Initiates: Outperform

Price Target: $40

Current: $26.80

Upside: +49.25%